CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With… (NCT02994654) | Clinical Trial Compass
CompletedNot Applicable
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
United States12 participantsStarted 2016-10
Plain-language summary
The overall purpose of this is study to provide continued access to the ReCell device following completion of protocol CTP001-6, and allow for collection of supplementary clinical outcome data for the ReCell device when used as an adjunct to meshed grafts in subjects with acute thermal burn injuries who require skin grafting for closure of burn injuries.
Who can participate
Age range5 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. The subject requires skin grafting as a result of an acute thermal burn injury (i.e. injuries caused by exposure of the skin to fire/flames, excessive heat, hot steam or water).
✓. The area of total burn injury is 5-50% TBSA inclusive.
✓. Two areas requiring skin grafting, each at least 300cm2 (or 600cm2 contiguous), excluding hand/face and joints.
✓. The subject is at least 5 years of age.
✓. The subject (or family, for those under 18 years of age) is willing and able to complete all follow-up evaluations required by the study protocol.
✓. The subject is to abstain from any other treatment of the wound(s) for the duration of the study unless medically necessary.
✓. The subject agrees to abstain from enrollment in any other interventional clinical trial for the duration of the study.
✓. The subject and/or guardian are able to read and understand instructions and give informed, voluntary, written consent.
Exclusion criteria
✕. The subject's burn injuries were caused by chemicals, electricity, and/or radioactive substances.
✕. The subject is unable to follow the protocol.
✕. The subject has other concurrent conditions that in the opinion of the investigator may compromise patient safety or study objectives.
What they're measuring
1
Number of Participants With Confirmed Treatment Area Closure of RECELL-treated Wounds Compared to Control (Non-inferiority)